Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds

On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredded documents tossed into a garbage truck. Over the next 10 days, the inspectors assessed what looked like a systematic effort to conceal quality problems at the plant, which provided more than ...

Read More

Men’s Health Month: A Focus on Skin Cancer Awareness with Skin Cancer & Dermatology Institute

Summer is here, and for many of us in the Northern Nevada area, it means participating in a variety of great outdoor activities. Whether you will be hiking, biking, or headed to the beach, you will be enjoying the fun in the sun after our long winter. June is Men’s Health Month and considering skin ...

Read More

Health Spending Growth Slowed In 2022. That Trend’s Set To Change, Experts Say

Experts predict that health spending growth will outstrip growth in the economy over the next decade, according to a study published in Health Affairs. Between 2022 and 2031, the actuaries predict spending will increase by 5.4% on average each year, faster than the estimated annual gross domestic product growth of 4.6%.

Read More

Satisfaction With Healthcare Coverage Spread Unevenly Across Payer Types: KFF Survey

Most people with either public or private healthcare insurance like their coverage—but they like it a lot less when they’re sick, according to a new KFF survey.

Read More

Labor Board Widens Definition Of Employee

The National Labor Relations Board (NLRB) returned Tuesday to an Obama-era standard for determining independent-contractor status — effectively broadening the number of people who have a protected right to unionize under the National Labor Relations Act.

Read More

Oncologists Urge Congress To Act On Cancer Drug Shortages

The House Energy & Commerce subcommittee on health held a hearing last week to examine avenues for improving preparedness against public health security risks. The hearing occurred amid an ongoing shortage of chemotherapy drugs in the U.S.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square